OTCMKTS:SEOVF Sernova Biotherapeutics (SEOVF) Stock Price, News & Analysis $0.08 0.00 (-3.35%) As of 10/13/2026 12:45 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Sernova Biotherapeutics Stock (OTCMKTS:SEOVF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SEOVF alerts:Sign Up Key Stats Today's Range$0.08▼$0.0850-Day Range$0.06▼$0.1052-Week Range$0.06▼$0.14Volume10,101 shsAverage Volume91,273 shsMarket Capitalization$29.46 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies designed to provide long-term treatment for chronic diseases. The company’s primary platform, the Cell Pouch System, is an implantable device intended to create a vascularized environment in the body where therapeutic cells can be placed and supported. Sernova has focused on cell-based therapies for conditions including type 1 diabetes, hemophilia A and thyroid disease. Its approach combines the Cell Pouch System with insulin-producing islet cells, blood-clotting factor-producing cells or other therapeutic cells, with the goal of restoring biological functions that are impaired by disease. The company has also explored technologies intended to protect transplanted cells from immune-system rejection and reduce or eliminate the need for chronic immunosuppressive drugs. Based in London, Ontario, Canada, Sernova has conducted research and clinical development activities in Canada and the United States. The company has been led by Dr. Philip Toleikis, who has served as president and chief executive officer. Its programs remain focused on advancing cell-based and regenerative therapies toward potential clinical applications.AI Generated. May Contain Errors. Read More Receive SEOVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SEOVF Stock News HeadlinesSernova Biotherapeutics Inc. (OTCMKTS:SEOVF) Sees Large Drop in Short InterestOctober 12 at 8:01 AM | americanbankingnews.comSernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical TrialOctober 5, 2026 | globenewswire.comMy next big call (under $1)The obvious way to "bet on Trump" in crypto is the Trump memecoin. And right now it's back in the news, with a contest offering its biggest holders a seat at dinner with the President. It's also about 97% below its peak. Because a memecoin doesn't benefit from good policy. It benefits from attention. The real winners of a pro-crypto Washington are the projects with actual businesses underneath them. Ones that get more valuable as rules get clearer, institutions get comfortable, and more money flows into the market.October 14 at 1:00 AM | Crypto 101 Media (Ad)Sernova Biotherapeutics Inc (SVA)September 25, 2026 | ca.investing.comSernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity ConferenceSeptember 25, 2026 | globenewswire.comSernova Biotherapeutics Inc SEOVFMay 14, 2026 | morningstar.comMSernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to ...March 4, 2026 | finanznachrichten.deSernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical EffortsNovember 13, 2025 | finance.yahoo.comSee More Headlines SEOVF Stock Analysis - Frequently Asked Questions How have SEOVF shares performed this year? Sernova Biotherapeutics' stock was trading at $0.0943 on January 1st, 2026. Since then, SEOVF stock has decreased by 17.3% and is now trading at $0.0780. How were Sernova Biotherapeutics' earnings last quarter? Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) released its quarterly earnings data on Thursday, September, 10th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.00. How do I buy shares of Sernova Biotherapeutics? Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/10/2026Today10/14/2026Fiscal Year End10/31/2026Next Earnings (Estimated)12/18/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SEOVF CIK1491434 Webwww.sernova.com Phone(519) 858-5184Fax519-858-5184EmployeesN/AYear Founded2006Profitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.24 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,111.49% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-1.56Miscellaneous Outstanding Shares377,640,000Free FloatN/AMarket Cap$29.46 million OptionableNot Optionable Beta0.89 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:SEOVF) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredElon's next millionaires start October 24?SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Biotherapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova Biotherapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
